A study in Portugal reveals that 1/3 of sexually active girls aged 15-19 use the morning-after pill, while 16% use no birth control.
Despite receiving contraceptive information in school, risks remain high for young women.
In Peru, controversy surrounds the morning-after pill, with legislators challenging its classification.
Concerns arise over easy access to emergency contraception, with debates on its impact on doctor visits and pregnancy rates.
The FDA's decision on nonprescription sales of Plan B sparks criticism and protests.
The issue of abortion, contraception, and access to reproductive healthcare continues to be contentious.
